Clinical Trials on Brain Metastasis in Belgium

Total 1258 results

Universitaire Ziekenhuizen KU Leuven

Recruiting

Local Ablative Therapy for Patients With Multiple (4-10) Brain Metastases (LAT-MUM)

Brain Metastases, Adult

Belgium
Jules Bordet Institute
GlaxoSmithKline; Schering-Plough

Completed

Lapatinib and Temozolomide for the Treatment of Progressive Brain Disease in HER-2 Positive Breast Cancer (LAPTEM)

Metastatic Breast Cancer | Brain Metastases | HER2 Positive

Belgium
Universitair Ziekenhuis Brussel

Recruiting

Evaluation of 68-GaNOTA-Anti-HER2 VHH1 Uptake in Brain Metastasis of Cancer Patients

Carcinoma | Receptor, ErbB-2

Belgium
Jules Bordet Institute
Bristol-Myers Squibb; La Fondation contre le cancer, Belgique; Les Amis de l'Institut... and other collaborators

Recruiting

A Brain Metastases Research Platform to Tackle the Challenge of CNS Metastases in Solid Tumours (BrainStorm)

CNS Metastases

Belgium, France, Luxembourg
University Hospital, Ghent
Flemish institute of biotechnology (VIB)

Recruiting

Single-Cell Transcriptomics of the Peritoneal Microenvironment of Colorectal PC (SingleCell)

Peritoneal Metastases

Belgium
Celyad Oncology SA

Terminated

Hepatic Transarterial Administrations of NKR-2 in Patients With Unresectable Liver Metastases From Colorectal Cancer (LINK)

Colon Cancer Liver Metastasis

Belgium
Jules Bordet Institute
Sanofi

Withdrawn

Evaluation of Cabazitaxel in Patients With Brain Metastasis Secondary to Breast Cancer and NSCLC (CRANIAL)

Breast Cancer | Non Small Cell Lung Cancer | Brain Metastasis

Belgium
Universitair Ziekenhuis Brussel

Completed

Intratumoral Injection of Autologous CD1c (BDCA-1)+ myDC, Avelumab, and Ipilimumab Plus Systemic Nivolumab (myDAvIpNi)

Solid Tumor | Metastases to Soft Tissue

Belgium
Celyad Oncology SA

Unknown

Dose Escalation and Dose Expansion Phase I Study to Assess the Safety and Clinical Activity of Multiple Doses of NKR-2 Administered Concurrently With FOLFOX in Colorectal Cancer With Potentially Resectable Liver Metastases (SHRINK)

Colon Cancer Liver Metastasis

Belgium
Janssen Research & Development, LLC
PharmaMar

Completed

A Study to Assess the Potential Effects of Ketoconazole on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies

Neoplasm Metastases

Belgium
University Hospital, Ghent

Terminated

Hair-sparing Whole Brain Radiotherapy

Small Cell Lung Cancer | Brain Metastases

Belgium
Universitaire Ziekenhuizen KU Leuven

Recruiting

SBRT in the Management of Solid Spinal Metastases

Spinal Metastases | Extradural Tumor

Belgium
HUYABIO International, LLC.
Bristol-Myers Squibb

Recruiting

Study Comparing Investigational Drug HBI-8000 Combined With Nivolumab vs. Nivolumab in Patients With Advanced Melanoma

Unresectable or Metastatic Melanoma | Progressive Brain Metastasis

Spain, United States, Italy, Japan, Belgium, France, New Zealand, Brazil, Korea, Republic of, Australia, Germany, Singapore, Czechia, Austria, South Africa, United Kingdom, Puerto Rico
Cancer Research Antwerp

Completed

A Trial to Improve Quality of Life With Stereotactic Body Radiotherapy for Patients With Painful Bone Metastases (ROBOMET)

Neoplasm Metastasis | Radiotherapy | Metastasis to Bone

Belgium
Cancer Research Antwerp

Completed

A Dose-escalation Trial of Stereotactic Ablative Body Radiotherapy for Non-spine Bone & Lymph Node Oligometastates (Destroy)

Metastatic Cancer

Belgium
Bayer

Completed

Extension Program for Bay 43-9006

Metastasis | Neoplasm

Canada, Belgium, Germany, United States
Medical Device Works NV SA
Celerion; Cromsource

Unknown

Liver-PILP First-in-Man (PILP FiM)

Liver Metastases

Belgium
University Hospital, Ghent

Completed

Biological Imaging Guided Antalgic Radiotherapy of Bone Metastases (Phase II Trial)

Bone Metastases

Belgium
Tools4Patient

Completed

A Study to Collect Data About Analgesia in Patients With Bone Metastasis

Bone Metastasis

Belgium, France
University Ghent

Completed

Whole Breast + Lymph Node Irradiation: Prone Compared to Supine Position in 15 or 5 Fractions (PRO-SURF)

Breast Neoplasms | Lymph Node Metastases | Radiotherapy

Belgium
University Hospital, Ghent

Unknown

Biological Image Guided Antalgic Stereotactic Body Radiotherapy of Bone Metastases

Bone Metastases

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Whole-Body 3D T1-weighted MR Imaging Anatomical Sequences: GE mDixon vs FSE (View) Approaches in Prostate Cancer. (TFE-TVE)

Metastasis | Prostate Adenocarcinoma

Belgium
Nektar Therapeutics

Completed

A Study of Etirinotecan Pegol (NKTR-102) Versus Treatment of Physician's Choice (TPC) in Patients With Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated With an Anthracycline, a Taxane, and Capecitabine (ATTAIN)

Breast Cancer | Metastasis

United States, Australia, Belgium, Canada, France, Israel, Italy, Portugal, Spain, United Kingdom
University Hospital, Ghent

Terminated

A Feasibility Study on the Use of F-18-FDG-PET and Optical Imaging in Evaluation of Radiation-induced Oral Mucositis

Squamous Cell Carcinoma of the Oral Cavity | Oropharynx Metastases | Lymph Metastases

Belgium
Brugmann University Hospital

Unknown

Magnetic Resonance Imaging of the Whole Body, Including Diffusion, in the Medical Evaluation of Breast Cancers at High Risk for Metastasis and the Follow-up of Metastatic Cancers

Metastatic Breastcancer

Belgium
Universitaire Ziekenhuizen KU Leuven

Unknown

Metachronic Brain Metastases After Esophagectomy for Esophageal Cancer (METABREC) (METABREC)

Esophageal Neoplasms | Brain Metastases | Esophagectomy

United States, France, Netherlands, Sweden, Belgium, Ireland
Cliniques universitaires Saint-Luc- Université...

Unknown

An Open Label Phase II Study Combining Nivolumab and Celecoxib in Patients With Advanced " Cold " Solid Tumors (NICE-COMBO)

Metastatic Cancer

Belgium
KU Leuven
Jules Bordet Institute; Erasme University Hospital; GZA Ziekenhuizen Campus Sint-Augustinus

Not yet recruiting

Clinical, Histological and In-depth Molecular Characterization as Well as Experimental Models of Liver Metastasis From Patients With Breast Cancer in Order to Identify New Potential Treatment Avenues. (OLiver Pro)

Breast Cancer | Liver Metastases

Belgium
Xenothera SAS

Recruiting

FIH XON7 in Advanced/Metastatic Solid Tumors (FIPO23)

Metastatic Cancer | Advanced Solid Tumor

France, Belgium
Universitair Ziekenhuis Brussel
Janssen, LP

Completed

Phase I:Decitabine by Hepatic Arterial Infusion(HAI) in Unresectable Liver Metastases Colorectal Cancer (CRC) (DECIT)

Colorectal Cancer | Liver Metastasis

Belgium
Cristal Therapeutics

Completed

A Study of CriPec® Docetaxel Given to Patients With Solid Tumours (NAPOLY)

Cancer | Metastatic Cancer | Solid Tumors

Netherlands, Belgium
Association pour la Recherche sur le Temps Biologique...
Pfizer; Merck Serono International SA; Gustave Roussy, Cancer Campus, Grand Paris and other collaborators

Unknown

Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of Chemotherapy (OPTILIV)

Metastatic Colorectal Cancer | Liver Metastases | Hepatic Lesions

France, Italy, Belgium, Portugal
The Belgian Society of Medical Oncology

Recruiting

The Belgian Molecular Profiling Program of Metastatic Cancer for Clinical Decision and Treatment Assignment

Metastatic Cancer

Belgium
European Organisation for Research and Treatment...
Japan Clinical Oncology Group; European Society of Surgical Oncology

Completed

Diffusion-Weighted MRI for Liver Metastasis (DREAM)

Colorectal Cancer | Colon Cancer Liver Metastasis | Malignant Neoplasm of Rectum Metastatic to Liver

France, Japan, Belgium, United States, Austria
The Belgian Society of Medical Oncology
Illumina, Inc.; OncoDNA; PierianDx

Recruiting

A Study to Examine the Clinical Value of Comprehensive Genomic Profiling Performed by Belgian NGS Laboratories: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Centre (BALLETT)

Solid Tumor | Metastatic Cancer

Belgium
The Belgian Society of Medical Oncology
Roche Pharma AG; Foundation Medicine; Sciensano

Recruiting

A Study to Examine the Value of Broad Agnostic Next Generation Sequencing (NGS) Panel Testing Versus Reimbursed Organ-directed NGS: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Center

Metastatic Cancer | Local Tumor Invasion

Belgium
Pfizer

Terminated

An Open-Label, Randomized, Multicenter Trial of Encorafenib + Binimetinib Evaluating a Standard-dose and a High-dose Regimen in Patients With BRAFV600-mutant Melanoma Brain Metastasis (POLARIS)

Brain Metastases

United States, Belgium, Australia, Argentina, Italy
Novartis Pharmaceuticals

Terminated

An Open-label, Dose Escalation Multi-center Study in Patients With Advanced Cancer to Determine the Infusion Rate Effect of ASA 404 With Paclitaxel Plus Carboplatin Regimen or Docetaxel on the Pharmacokietics of Free and Total ASA404

Metastatic Cancer With Impaired Renal Function | Metastatic Cancer With Normal Renal Function

Belgium
GlaxoSmithKline

Terminated

Brain Metastases In ErbB2-Positive Breast Cancer

Neoplasms, Breast

United States, Spain, Israel, Canada, Germany, Belgium, Austria, Sweden, Greece, France, Italy
AstraZeneca
Daiichi Sankyo

Completed

A Study of T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast Cancer (DESTINY-B12)

Breast Cancer

Denmark, Finland, Italy, Norway, Spain, Sweden, Poland, United States, Canada, Germany, Japan, Netherlands, Portugal, Switzerland, Australia, United Kingdom, Belgium, Ireland
Universitaire Ziekenhuizen KU Leuven

Completed

Whole Body Diffusion MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Ovarian Cancer and Peritoneal Metastasis

Ovarian Cancer | Peritoneal Metastasis

Belgium
Novartis Pharmaceuticals

Completed

Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer

Neoplasms, Breast

Spain, Canada, United States, Australia, Austria, Italy, Japan, Poland, Sweden, France, Germany, Switzerland, Taiwan, United Kingdom, Belgium, Greece, India
Novartis Pharmaceuticals

Completed

Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer

Metastases, Brain

Spain, Hungary, Poland, Germany, Italy, Russian Federation, Sweden, United Kingdom, Thailand, United States, Belgium, France, Greece, Denmark
BBB-Therapeutics B.V.

Completed

An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.

Melanoma | Breast Cancer | Lung Cancer | Malignant Glioma | Brain Metastases

United States, Netherlands, France, Belgium
European Organisation for Research and Treatment...
Roche Pharma AG; Amgen

Terminated

Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver Metastases (BOS2)

Colorectal Cancer Metastatic | Liver Metastases | KRAS Wild Type Colorectal Cancer

France, Belgium, Austria, Netherlands, Spain, Switzerland
Amal Therapeutics
Boehringer Ingelheim

Active, not recruiting

Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer (KISIMA-01)

Metastatic Colorectal Cancer | Colorectal Cancer | Liver Metastasis Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal Cancer | MSS

United States, Belgium, Switzerland, Germany
University Ghent
University Hospital, Geneva

Active, not recruiting

PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases (STORM)

Prostate Cancer | Metastatic Cancer | Prostate Cancer Metastatic | Oligometastatic Cancer

Norway, Spain, Belgium, Switzerland, Australia, Italy
Maastricht University
Koningin Wilhelmina Fonds

Recruiting

DRAGON 1- Training, Accreditation, Implementation and Safety Evaluation of Combined PVE/HVE (DRAGON)

Colorectal Cancer Liver Metastases

United States, Canada, Netherlands, Italy, United Kingdom, Belgium, Australia, Austria, Germany, Norway, Spain, Sweden, Switzerland
Spectrum Pharmaceuticals, Inc

Completed

Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases

Metastatic Cancer

France, United States, Canada, Belgium, Italy, Australia, United Kingdom, Germany, Hungary
University Hospital, Ghent
University Ghent

Terminated

Olfactive Discriminative Ability of Dogs When Confronted With Seizure and Non-seizure Samples // Identification of Potential Biomarkers for Epilepsy in Human Sweat.

Epilepsy

Belgium

Clinical Trials on Brain Metastasis in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations